Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot study-Reference-Cited by-同舟云学术

Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot study

Published:2018-12-03 Issue:3 Volume:24 Page:249-254
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Siebuhr Anne Sofie¹^ORCID,Juhl Pernille¹,Bay-Jensen Anne-C¹^ORCID,Karsdal Morten A.¹,Franchimont Nathalie²,Chavez Juan C.²

Affiliation:

1. Department of Rheumatology, Biomarkers and Research, Nordic Bioscience, Herlev, Denmark;

2. Clinical Development, Biogen, Cambridge, MA, USA

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2018.1548032

Reference36 articles.

1. Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis

2. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis

3. The Current State of Biomarkers in Systemic Sclerosis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis;RMD Open;2024-05

2. A biological guide to glycosaminoglycans: current perspectives and pending questions;The FEBS Journal;2024-03-18

3. Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury;Journal of Clinical Medicine;2022-10-27

4. Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance;Molecular and Cellular Biochemistry;2021-06-28

5. Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study;The Lancet Rheumatology;2021-03